• Home
  • Distribution
  • Consulting
    • Marketing services
    • Alliance management
    • Regulatory and legal affairs
    • Clinical trials
  • About us
  • Blog
  • Español
  • linkedin
contact us


Home

Distribution

CONSULTING

Marketing services

Alliance management

Regulatory and legal affairs

Clinical trials

BLOG

ABOUT US

Contact us
  • Español
  • linkedin
CMC Pharma Solutions promotes the visit of Canè Directors to reference medical centers in Buenos Aires

CMC Pharma Solutions promotes the visit of Canè Directors to reference medical centers in Buenos Aires

by cmcphsolcmc | May 30, 2023 | CMC

Mr. Paolo Canè and Mr. Claudio Canè, Managing Directors of CANÈ MEDICAL TECHNOLOGY, visited the hospital of the Centro Gallego de Buenos Aires.They have been received by Dr. Adrían Lescano and his team. Mr. Paolo Canè and Mr. Claudio Canè with Dr. Adrían Lescano and...
CMC Pharma Solutions organizes the visit of Argentine Opinion Leaders to the Canè Medical Tecnology facilities

CMC Pharma Solutions organizes the visit of Argentine Opinion Leaders to the Canè Medical Tecnology facilities

by cmcphsolcmc | Mar 20, 2023 | CMC

Doctors Guillermo Bortman, David Peña and Sergio Perrone, leaders in Argentina and Latin America in the treatment of pulmonary arterial hypertension, visited the CANÈ facilities in Rivoli (Italy). They were received by Messrs. Paolo Canè and Claudio Canè, Managing...
INVIMA has just granted a Marketing Authorization to the CRONO SC ambulatory infusion pump of Canè Medical Technology

INVIMA has just granted a Marketing Authorization to the CRONO SC ambulatory infusion pump of Canè Medical Technology

by cmcphsolcmc | Dec 9, 2022 | CMC

CMC Pharma Solutions and its distributor in Colombia, Pyxis Pharmaceutical, are thrilled to announce that the Instituto Nacional de Vigilancia de Medicamentos y Alimentos de Colombia – INVIMA has just granted a Marketing Authorization to the CRONO SC...
Signature of an agreement between CMC Pharma Solutions and CHEMTEST Argentina

Signature of an agreement between CMC Pharma Solutions and CHEMTEST Argentina

by cmcphsolcmc | Apr 21, 2021 | CMC

Both companies have just signed a Product Registration Services Agreement, with the aim of achieving the CE mark for the in vitro diagnostic medical device ELA CHEMSTRIP COVID-19. The elaboration of the Technical File to be presented in the certification and...
The treatment of patients with Primary Immunodeficiency disorders (PID)

The treatment of patients with Primary Immunodeficiency disorders (PID)

by cmcphsolcmc | Aug 25, 2020 | CMC

Patients with PID disorders are born without some of the body’s immune defenses or with an immune system that is not working properly. These people suffer more frequent, longer lasting or difficult to treat infections than the infections suffered by people with a...
Signature of a Guidance and strategic Support agreement between                 AIO Health Pro and Dermclar

Signature of a Guidance and strategic Support agreement between AIO Health Pro and Dermclar

by cmcphsolcmc | Jul 30, 2020 | CMC

Both companies have just signed a Guidance and strategic Support agreement for the launch in Spain of the Dermclar Professional and Personal Care lines. The agreement has been made possible thanks to the intermediation of CMC Pharma Solutions. The signed...
« Older Entries

Entradas recientes

  • CMC Pharma Solutions promotes the visit of Canè Directors to reference medical centers in Buenos Aires
  • CMC Pharma Solutions organizes the visit of Argentine Opinion Leaders to the Canè Medical Tecnology facilities
  • INVIMA has just granted a Marketing Authorization to the CRONO SC ambulatory infusion pump of Canè Medical Technology
  • CRONO SC portable pump
  • CRONO PAR4 20 ambulatory infusion pump

Comentarios recientes

No comments to show.

Contact us



info@cmcphsolutions.com

Offices



Miami



Buenos Aires



Barcelona

Services

Distribution

Consulting

– Marketing services

– Alliance management

– Regulatory and legal affairs

– Clinical trials

CMC Pharma solutions

About us

Contact

NEWS

Blog

Linkedin

© CMC Pharma Solutions 2022 

EN
EN
ES